LANTHIOPEP BV has a total of 56 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AMUNIX OPERATING INC, ALDERBIO HOLDINGS LLC and TOPOTARGET SWITZERLAND SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 7 | |
#3 | Australia | 6 | |
#4 | WIPO (World Intellectual Property Organization) | 6 | |
#5 | Canada | 5 | |
#6 | China | 5 | |
#7 | Republic of Korea | 3 | |
#8 | Hungary | 2 | |
#9 | Israel | 2 | |
#10 | Mexico | 2 | |
#11 | New Zealand | 2 | |
#12 | Russian Federation | 2 | |
#13 | Singapore | 2 | |
#14 | Brazil | 1 | |
#15 | Japan | 1 | |
#16 | Serbia | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Fermentation | |
#6 | Analysing materials | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Rink Rick | 26 |
#2 | Moll Gert Nikolaas | 18 |
#3 | Kuipers Anneke | 16 |
#4 | De Vries Louwe | 15 |
#5 | Bosma Tjibbe | 13 |
#6 | Nelemans Sieger Adriaan | 13 |
#7 | Roks Antonius Jacobus Marinus | 12 |
#8 | Rick Rink | 5 |
#9 | Urban Johannes Herbert | 4 |
#10 | Prassler Josef | 4 |
Publication | Filing date | Title |
---|---|---|
WO2021023698A1 | Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer | |
CN107531803A | Ring-type galanin analog and application thereof | |
BR112016021835A8 | cyclic analog of apelin of general formula x1-x2-x3-x4-x5-x6-x7-x8-x9-x10-x11-x12-x13-x14, pharmaceutical composition, and method for providing an analogue of apelin | |
EP2578599A1 | Cyclic analogs of GLP-1 and GLP-1 related peptides | |
EP2455388A1 | Novel angiotensin type 2 (AT2) receptor agonists and uses thereof. | |
EP2405008A1 | Bacterial surface display of thioether-bridge-containing peptides |